Orca Bio

📍 Menlo Park, United States🗓 Founded 2016👥 135 employees💰 Last funded Oct 2018
Pharmaceutical Manufacturing🌐 orcabio.com
Website LinkedIn
Orca Bio is a clinical-stage biotechnology company developing a pipeline of high precision allogeneic cell therapy products that are designed to safely replace patients’ diseased blood and immune system with a healthy one. Our manufacturing platform sorts donor blood with single-cell precision and a high level of purity and speed, enabling us to create proprietary, optimal therapeutic mixtures of immune and stem cells that have the potential to transform allogeneic cell therapy. Our talented team is driven by a passion for science and compassion for patients.
5
Total investors
5
Early stage
0
Mid stage
0
Late stage
2016
Founded

Investors

5 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
5
Investor activity2016–2018 · investors recorded per year
201612017120183
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Orca Bio?
Orca Bio has 5 investors on record on gritt.io, including 5 early-stage backers.
When did Orca Bio last raise funding?
The most recent investment in Orca Bio recorded on gritt.io was in October 2018.
When was Orca Bio founded?
Orca Bio was founded in 2016.
What industry is Orca Bio in?
Orca Bio operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Orca Bio based?
Orca Bio is headquartered in Menlo Park, United States.